Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RAB9AP1 is a pseudogene corresponding to the RAB9A, member RAS oncogene family. Pseudogenes are typically non-functional genomic DNA sequences similar to normal genes but generally considered incapable of coding for functional proteins[1]. There is no evidence that this pseudogene encodes a functional protein product or that it serves as a therapeutic target. RAB9A is a functional small GTPase involved in vesicle trafficking, but RAB9AP1 is a pseudogene—a non-coding, likely nonfunctional DNA segment related to RAB9A[1][7]. RAB9AP1 should not be confused with RAB9A (a bona fide protein), which is involved in endosome-to-Golgi transport as part of the Rab small GTPase family and has well-characterized roles in membrane trafficking[2][3][7]. There are no reported drugs, mechanisms of action, or disease indications for RAB9AP1, as it does not produce a protein. This entry refers to a non-coding pseudogene, not a therapeutic or research target[1]. If you intended to refer to the functional RAB9A protein, information should be based on that gene instead.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RAB9A, member RAS oncogene family pseudogene 1 (RAB9AP1).